HELLP syndrome associated with factor V R506Q mutation

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 999-1001

  Brenner, Benjamin ^a   Lanir, Naomi ^a   Thaler, Israel ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Factor V; HELLP syndrome; Protein C; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTEIN C;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; HELLP SYNDROME; HUMAN; PREGNANCY; PRIORITY JOURNAL; THROMBOSIS;

ADULT; FACTOR V; FEMALE; HELLP SYNDROME; HUMANS; MUTATION; PREGNANCY; PROTEIN C;

EID: 0029874642     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.410947.x     Document Type: Article

References (10)

1. Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van der Veiden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
2. Cumming, A.M., Trait, R.C., Fildes, S., Yoong, A., Keeney, S. & Hay, C.R.M. (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology, 90, 725-727.
3. Davidson, S.J., Redman, C. & Littlewood, T.J. (1995) Resistance to activated protein C in normal and complicated pregnancy. (Abstract). Blood Coagulation and Fibrinolysis, 6, 160.
4. Greengard, J.S., Sun, X., Xu, X., Fernandez, J.A., Griffin, J.H. & Evatt, B. (1994) Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet, 343, 1362-1363.
5. Griffin, J.H., Evatt, B., Widerman, C. & Fernandez, J.A. (1993) Anticoagulant protein C pathway is defective in majority of thrombophilic patients. Blood, 82, 1989.
6. Hellgren, M., Svensson, P.J. & Dahlback, B. (1995) Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. American Journal of Obstetrics and Gynecology (in press).
7. Martin, J.N., Blake, P.G. & Perry, K.G. (1991) The natural history of HELLP syndrome: pattern of disease progression and regression. American Journal of Obstetrics and Gynecology, 164, 1500-1509.
8. Svensson, P.J. & Dahlback, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 300, 517-522.
9. Vandenbroucke, J.P., Koster, T., Briet, E., Reitsma, P.H., Bertina, R.M. & Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 1453-1457.
10. Weinstein, L. (1982) Syndrome of hemolysis elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology, 142, 159-167.